Publication Date:
2015-10-08
Description:
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey Leukemia 29, 2062 (October 2015). doi:10.1038/leu.2015.212 Authors: R Zeiser, A Burchert, C Lengerke, M Verbeek, K Maas-Bauer, S K Metzelder, S Spoerl, M Ditschkowski, M Ecsedi, K Sockel, F Ayuk, S Ajib, F S de Fontbrune, I-K Na, L Penter, U Holtick, D Wolf, E Schuler, E Meyer, P Apostolova, H Bertz, R Marks, M Lübbert, R Wäsch, C Scheid, F Stölzel, R Ordemann, G Bug, G Kobbe, R Negrin, M Brune, A Spyridonidis, A Schmitt-Gräff, W van der Velden, G Huls, S Mielke, G U Grigoleit, J Kuball, R Flynn, G Ihorst, J Du, B R Blazar, R Arnold, N Kröger, J Passweg, J Halter, G Socié, D Beelen, C Peschel, A Neubauer, J Finke, J Duyster & N von Bubnoff
Print ISSN:
0887-6924
Electronic ISSN:
1476-5551
Topics:
Medicine
Permalink